SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001610618-22-000011
Filing Date
2022-03-07
Accepted
2022-03-07 17:21:36
Documents
5
Effectiveness Date
2022-03-07
Reference 429
333-253545

Document Format Files

Seq Description Document Type Size
1 FORM S-8 cdtxs-82022x03x07.htm S-8 57063
2 CALCULATION OF FILING FEE TABLES exhibit1072022-03x07.htm EX-FILING FEES 19474
3 CONSENT OF COOLEY LLP exhibit512022-03x07.htm EX-5.1 9664
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM exhibit2312022-03x07.htm EX-23.1 2688
5 GRAPHIC cooleylogoa05.jpg GRAPHIC 38052
  Complete submission text file 0001610618-22-000011.txt   140870
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-263350 | Film No.: 22719188
SIC: 2836 Biological Products, (No Diagnostic Substances)